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cines in the public offer. Here, we analysed the impact of these
new medicines ﬁnanced by the Spanish NHS over the period
1996–2003, as a continuation of a previous one. METHODS: A
retrospective analysis has been made, selecting new medicines.
These have been classiﬁed following the degree of therapeutic
innovation at the moment of authorisation, according to two 
criteria, the Ministry of Health and Consume (MHC) and the
Drug Information Centre of Andalusia Autonomous Commu-
nity, (CADIME). Consume data were provided by the MHC
database and was expressed as Price for sale Direct to Customer,
tax-free (PDC), by means of millions of Euro (M€). The rapid
introduction of new medicines into the clinical practice (next to
one-hundred top) and the evolution of the consumption were 
the indicators used. RESULTS: The total number of new drugs
marketed during the period of the study was 113. From those,
20 are next to one-hundred top in the ﬁrst year after authorisa-
tion. None of them were categorised as “an exceptional thera-
peutic novelty”. Most were drugs with “non o very small
therapeutic improvement” or “insufﬁcient clinical evidence”
according to the MHC and CADIME classiﬁcation, respectively.
Different status of classiﬁcation was found in more than six of
the 20 new drugs. When analysing new drug consumption, it
detected that their quote is superior to 1.9%, in average, in rela-
tion to the public annual consumption. CONCLUSIONS: The
market size, devoted to recently introduced medicines with high
prices, is important. This is not in agreement with their limited
therapeutic innovation, being even least when CADIME classiﬁ-
cation is considered. Nevertheless, a notable decrease in the
number of “innovator” drugs introduced from the year 2001
was observed.
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OBJECTIVES: To compare willingness to pay (WTP) with out
of pocket (OoP) payments of the Greek population for primary
and secondary health services utilization. METHODS: A 
telephone survey was conducted in 2003, covering a national
random sample of 1000 participants questioned regarding their
additional WTP and OoP actual payments, for a 12 month
period, in order to improve their provision of health services in
terms of NHS responsiveness and access to health care.
RESULTS: A total of 95.6% respondents were compulsory
insured, 55.8% of WTP respondents were male, 53.8% of non
WTP female. Mean age of WTP respondents was 42.1 years. A
total of 63% urban residents, 13% semi-urban and 23.8% rural.
Twenty percent (20%) of those who declared WTP had an
income per month from 900 to 1500€, 14.7% from 501 to 900€,
20% from 1501 to 3000€ and the rest (37.8%) had an income
over 3001€. Of those who denied WTP, only 16.4% had spent
nothing as OoP payments for health services utilization during
the last year, 46.9% spent up to 150€, 14.2% spent from 151
to 300€, 8% from 301 to 600€, 6.4% from 600 to 1500€ and
2.3% over 1501€. According to the WTP amount already
declared, 62.8% of those willing to pay from 0 to 50€ had actu-
ally spent approximately a total of 150€ for health services uti-
lization during the last 12 months, while 100% of those willing
to pay from 601 to 900€ had only spent up 150€. CONCLU-
SIONS: A total of 70.8% of respondents declared non WTP for
improving their access and utilization of primary and hospital
care. Among the respondents who denied WTP, 83.6% declared
OoP actual payments starting from 150 to 1500€ per year. Our
ﬁndings may reﬂect the difference between revealed and stated
populations’ preferences.
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OBJECTIVES: The objective of the study was to identify differ-
ent GP’s practicing proﬁles, in order to better understand the way
French GP’s react to governmental measures to contain cost or
to increase quality of care. METHODS: We constructed a large
database about of 4700 GP’s from 2 French regions (Aquitaine
and Burgundy) for the year 2000. Variables described physicians’
volume and structure of medical activity (ofﬁce consultations,
home visits, medical procedures, prescriptions of pharmaceuti-
cal, lab tests and X-rays examinations), income level, personal
characteristics (age, gender, speciality, localisation, contractual
status with health insurance), practice characteristics (size, 
structure by age, percentage of hospitalised patients, etc.) and
socio-economic characteristics of the geographical environment
(physicians density, distance to the nearest hospital, unemploy-
ment rate, urban or rural town). The database was analysed
though a variety of statistical methods including cluster analysis
and econometric tests. RESULTS: Four different homogeneous
groups were identiﬁed, each of them relating physicians’ level of
activity to their socio-economic status. In group 1 for instance,
GP’s have a high level of activity (2340 patients and 9300 con-
sultations in average), 46% of them practice in rural areas and
only 4% are women. Conversely, physicians in group 4 have 
a low level of activity (1050 patients, 2400 consultations in
average), 75% are located in urban areas and 44% are women.
Econometric tests allow discriminating the main determinants of
multidimensional medical activity between rural and urban GP’s.
CONCLUSIONS: The way GP’s exert medicine is not uniform.
The level and the type of medical activity greatly vary among
physicians. Individual factors as well as characteristics of the
socio-economic environment greatly explain these differences.
An immediate consequence is that any cost-containment measure
which applies uniformly to all GP’s, such as regulating fees, 
necessarily results in different outcomes according to the type of
physicians’ category.
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OBJECTIVES: To highlight the importance in establishing age
and gender bands with the aim of explaining the level of phar-
maceutical expenditure of each Primary Health Care Team
(PHCT). METHODS: Thanks to the advances of information
systems and the introduction of the Personal Health Card, it has
been possible to calculate the cost per inhabitant (according to
age and gender) taking into account the expense generated
through prescriptions produced by inhabitants assigned to the
Public Health System (Central Register of Insured). RESULTS:
According to some established criteria, 20 bands have been
determined. It is proved that 10% of the population is concen-
trated in the 67–77 year old band and the expenditure that it
generates is 33% of the total expense. However, the 9–12 year
old and 33–39 year old bands together (15% of the population)
only represent 3.8% of the total expense. Gender is also a rele-
vant variable. Women have a higher level of expense than men
for ages comprised between 21 and 72 and for those above 89
